Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver.
Villela-Nogueira CA, Ferraz MLG, Pessoa MG, Souto FJD, Nabuco LC, Coelho HSM, Ridruejo E, Silva M, Bittencourt PL, Brandão-Mello CE; Members of the Brazilian Society of Hepatology. Villela-Nogueira CA, et al. Among authors: ferraz mlg. Ann Hepatol. 2023 Jan-Feb;28(1):100764. doi: 10.1016/j.aohep.2022.100764. Epub 2022 Sep 28. Ann Hepatol. 2023. PMID: 36182033 Free article.
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study Group. Poynard T, et al. Gastroenterology. 2009 May;136(5):1618-28.e2. doi: 10.1053/j.gastro.2009.01.039. Epub 2009 Jan 22. Gastroenterology. 2009. PMID: 19208349 Clinical Trial.
Disease burden of chronic hepatitis C in Brazil.
Ferreira PR, Brandão-Mello CE, Estes C, Gonçales Júnior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, Mendes-Correa MC. Ferreira PR, et al. Braz J Infect Dis. 2015 Jul-Aug;19(4):363-8. doi: 10.1016/j.bjid.2015.04.004. Epub 2015 Jun 4. Braz J Infect Dis. 2015. PMID: 26051505 Free PMC article.
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: ferraz mlg. Dig Dis Sci. 2022 Jul;67(7):3305-3312. doi: 10.1007/s10620-021-07122-y. Epub 2021 Jun 28. Dig Dis Sci. 2022. PMID: 34181166
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, Gomes NMF, de Oliveira EMG, Rotman V, de Oliveira MB, da Cunha SMCF, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: ferraz mlg. Ann Hepatol. 2022 Jan-Feb;27(1):100546. doi: 10.1016/j.aohep.2021.100546. Epub 2021 Sep 30. Ann Hepatol. 2022. PMID: 34600142 Free article.
Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study.
Cançado GGL, Couto CA, Guedes LV, Braga MH, Terrabuio DRB, Cançado ELR, Ferraz MLG, Villela-Nogueira CA, Nardelli MJ, Faria LC, de Oliveira EMG, Rotman V, Mazo DFC, Borges VFAE, Mendes LSC, Codes L, Pessoa MG, Signorelli IV, Levy C, Bittencourt PL. Cançado GGL, et al. Among authors: ferraz mlg. Front Pharmacol. 2022 Jan 20;12:818089. doi: 10.3389/fphar.2021.818089. eCollection 2021. Front Pharmacol. 2022. PMID: 35126149 Free PMC article.
National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.
Ferraz MLG, Piccoli LZ, Rezende R, Borba LA, Junior AP, Cheinquer H, Silva GF, Ferreira PRA, Villela-Nogueira CA, Mazo DF, Souza FF, Codes L, Ivantes CAP, Gomide GPM, Pereira GHS, Pessôa MG, França AVC, Pinto ADS, Teixeira R, Bittencourt PL. Ferraz MLG, et al. Braz J Infect Dis. 2022 Jul-Aug;26(4):102388. doi: 10.1016/j.bjid.2022.102388. Epub 2022 Jul 26. Braz J Infect Dis. 2022. PMID: 35905930 Free PMC article.
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
Cançado GGL, Couto CA, Terrabuio DRB, Cançado ELR, Villela-Nogueira CA, Ferraz MLG, Braga MH, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Guedes LV, Signorelli IV, Coral GP, Levy C, Bittencourt PL; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: ferraz mlg. Dig Dis Sci. 2023 Feb;68(2):514-520. doi: 10.1007/s10620-022-07654-x. Epub 2022 Aug 22. Dig Dis Sci. 2023. PMID: 35989386
102 results